Review: Improving symptom control in early Parkinson’s disease by Stuart H. Isaacson, Robert A. Hauser

Get full text

Non-Oral Drug Delivery Strategies: From Early Diagnosis to Advanced Treatments by Claudia Trenkwalder, Werner Poewe, Fabrizio Stocchi, Stuart H. Isaacson

Get full text

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease by Bruno Bergmans, Veronica Clark, Stuart H. Isaacson, Tobias Bäumer

Get full text

Ondansetron for the treatment of Parkinson’s disease psychosis: Rationale and literature review by Jaslovleen Kaur, Abhishek Lenka, Jonathan R Isaacson, Stuart H Isaacson

Get full text

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier? by Stuart H. Isaacson, Fernando L. Pagan, Mark F. Lew, Rajesh Pahwa

Get full text

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment by Stuart H. Isaacson, Robert A. Hauser, Rajesh Pahwa, David Gray, Sridhar Duvvuri

Get full text

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature by Stuart H. Isaacson, Richard B. Dewey, Jr., Rajesh Pahwa, Daniel E. Kremens

Get full text

Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel by Rajesh Pahwa, Stuart H. Isaacson, Gary W. Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh

Get full text

Correction to: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel by Rajesh Pahwa, Stuart H. Isaacson, Gary W. Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh

Get full text

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions by Mark F. Lew, Robert A. Hauser, Stuart H. Isaacson, Daniel Truong, Atul T. Patel, Allison Brashear, William Ondo, Pascal Maisonobe, Khashayar Dashtipour, Laxman Bahroo, Stefan Wietek

Get full text

Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase... by Cynthia Comella, Robert A. Hauser, Stuart H. Isaacson, Daniel Truong, Odinachi Oguh, Jennifer Hui, Eric S. Molho, Matthew Brodsky, Erin Furr-Stimming, Georg Comes, Michael A. Hast, David Charles

Get full text

Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson’s disease: Post-hoc analyses from a large 54-week trial by Rajesh Pahwa, Jason Aldred, Aristide Merola, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R. Steffen, Prasanna L. Kandukuri, Yanjun Bao, Omar Ladhani, Connie H. Yan, Vivek Chaudhari, Stuart H. Isaacson

Get full text

LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort by Tatiana Usnich, Eva-Juliane Vollstedt, Nathalie Schell, Volha Skrahina, Xenia Bogdanovic, Hanaa Gaber, Toni M. Förster, Andreas Heuer, Natalia Koleva-Alazeh, Ilona Csoti, Ayse Nazli Basak, Sibel Ertan, Gencer Genc, Peter Bauer, Katja Lohmann, Anne Grünewald, Emma L. Schymanski, Joanne Trinh, Susen Schaake, Daniela Berg, Doreen Gruber, Stuart H. Isaacson, Andrea A. Kühn, Brit Mollenhauer, David J. Pedrosa, Kathrin Reetz, Esther M. Sammler, Enza Maria Valente, Franco Valzania, Jens Volkmann, Simone Zittel, Norbert Brüggemann, Norbert Brüggemann, Meike Kasten, Meike Kasten, Arndt Rolfs, Christine Klein, The LIPAD Study Group

Get full text